Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Canadian Cancer Society. Cancer-Specific-Stats 2020. 2020. Available online: https://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics%20supplementary%20information/2020/2020_cancer-specific-stats.pdf?la=en (accessed on 30 November 2020).
- Edwards, B.K.; Howe, H.L.; Ries, L.A.; Thun, M.J.; Rosenberg, H.M.; Yancik, R.; Wingo, P.A.; Jemal, A.; Feigal, E.G. An-nual Report to the Nation on the Status of Cancer, 1973-1999, Featuring Implications of Age and Aging on U.S. Cancer Bur-den. Cancer 2002, 94, 2766–2792. [Google Scholar] [CrossRef] [PubMed]
- Quinn, M.J.; D’Onofrio, A.; Møller, B.; Black, R.; Martinez-Garcia, C.; Møller, H.; Rahu, M.; Robertson, C.; Schouten, L.J.; La Vecchia, C.; et al. Cancer mortality trends in the EU and acceding countries up to 2015. Ann. Oncol. 2003, 14, 1148–1152. [Google Scholar] [CrossRef]
- Scheele, J.; Stang, R.; Altendorf-Hofmann, A.; Paul, M. Resection of colorectal liver metastases. World J. Surg. 1995, 19, 59–71. [Google Scholar] [CrossRef] [PubMed]
- Ito, K.; Govindarajan, A.; Ito, H.; Fong, Y. Surgical Treatment of Hepatic Colorectal Metastasis: Evolving Role in the Setting of Improving Systemic Therapies and Ablative Treatments in the 21st Century. Cancer J. 2010, 16, 103–110. [Google Scholar] [CrossRef]
- Fata, F.; Mirza, A.; Craig Wood, G.; Nair, S.; Law, A.; Gallagher, J.; Ellison, N.; Bernath, A. Efficacy and Toxicity of Adjuvant Chemotherapy in Elderly Patients with Colon Carcinoma: A 10-Year Experience of the Geisinger Medical Center. Cancer 2002, 94, 1931–1938. [Google Scholar] [CrossRef]
- André, T.; Boni, C.; Mounedji-Boudiaf, L.; Navarro, M.; Tabernero, J.; Hickish, T.; Topham, C.; Zaninelli, M.; Clingan, P.; Bridgewater, J.; et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N. Engl. J. Med. 2004, 350, 2343–2351. [Google Scholar] [CrossRef] [Green Version]
- Sargent, D.J.; Goldberg, R.M.; Jacobson, S.D.; Macdonald, J.S.; Labianca, R.; Haller, D.G.; Shepherd, L.E.; Seitz, J.F.; Francini, G. A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients. N. Engl. J. Med. 2001, 345, 1091–1097. [Google Scholar] [CrossRef]
- Tournigand, C.; André, T.; Bonnetain, F.; Chibaudel, B.; Lledo, G.; Hickish, T.; Tabernero, J.; Boni, C.; Bachet, J.B.; Teixeira, L.; et al. Adjuvant Therapy with Fluorouracil and Oxaliplatin in Stage Ii and Elderly Patients (between Ages 70 and 75 Years) with Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial. J. Clin. Oncol. 2012, 30, 3353–3360. [Google Scholar]
- Duron, J.J.; Duron, E.; Dugue, T.; Pujol, J.; Muscari, F.; Collet, D.; Pessaux, P.; Hay, J.M. Risk Factors for Mortality in Major Digestive Surgery in the Elderly: A Multicenter Prospective Study. Ann. Surg. 2011, 254, 375–382. [Google Scholar] [CrossRef]
- Gryspeerdt, F.; Vandenbroucke-Menu, F.; Lapointe, R.; Turcotte, S.; Dagenais, M.; Plasse, M.; Letourneau, R.; Roy, A. Hepatectomy for malignancy in the aged population: A comparative study. HPB 2019, 21, S99. [Google Scholar] [CrossRef] [Green Version]
- Charlson, M.E.; Pompei, P.; Ales, K.L.; MacKenzie, C. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J. Chronic Dis. 1987, 40, 373–383. [Google Scholar] [CrossRef]
- Dell’Aquila, E.; Cremolini, C.; Zeppola, T.; Lonardi, S.; Bergamo, F.; Masi, G.; Stellato, M.; Marmorino, F.; Schirripa, M.; Urbano, F.; et al. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: A retrospective analysis of the TRIBE study by GONO. Ann. Oncol. 2018, 29, 924–930. [Google Scholar] [CrossRef]
- Douillard, J.Y.; Oliner, K.S.; Siena, S.; Tabernero, J.; Burkes, R.; Barugel, M.; Humblet, Y.; Bodoky, G.; Cunningham, D.; Jassem, J.; et al. Panitumumab–Folfox4 Treatment and Ras Mutations in Colorectal Cancer. N. Engl. J. Med. 2013, 369, 1023–1034. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Venook, A.P.; Niedzwiecki, D.; Lenz, H.J.; Innocenti, F.; Mahoney, M.R.; O’Neil, B.H.; Shaw, J.E.; Polite, B.N.; Hochster, H.S.; Atkins, J.N.; et al. Calgb/Swog 80405: Phase Iii Trial of Irinotec-an/5-Fu/Leucovorin (Folfiri) or Oxaliplatin/5-Fu/Leucovorin (Mfolfox6) with Bevacizumab (Bv) or Cetuximab (Cet) for Pa-tients (Pts) with Kras Wild-Type (Wt) Untreated Metastatic Adenocarcinoma of the Colon or Rectum (Mcrc). J. Clin. Oncol. 2014, 32, LBA3. [Google Scholar]
- Nordlinger, B.; Sorbye, H.; Glimelius, B.; Poston, G.J.; Schlag, P.M.; Rougier, P.; O Bechstein, W.; Primrose, J.N.; Walpole, E.; Finch-Jones, M.; et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2013, 14, 1208–1215. [Google Scholar] [CrossRef]
- Manceau, G.; Karoui, M.; Werner, A.; Mortensen, N.J.; Hannoun, L. Comparative outcomes of rectal cancer surgery between elderly and non-elderly patients: A systematic review. Lancet Oncol. 2012, 13, e525–e536. [Google Scholar] [CrossRef]
- Jin, K.-M.; Wang, K.; Bao, Q.; Wang, H.W.; Xing, B.C. Liver Resection for Colorectal Liver-Limited Me-tastases in Elderly Patients: A Propensity Score Matching Analysis. World J. Surg. Oncol. 2020, 18, 275. [Google Scholar] [CrossRef] [PubMed]
- Chandrasinghe, P.C.; Ediriweera, D.S.; Nazar, T.; Kumarage, S.; Hewavisenthi, J.; Deen, K.I. Overall Survival of Elderly Patients Having Surgery for Colorectal Cancer Is Comparable to Younger Patients: Results from a South Asian Population. Gastroenterol. Res. Pract. 2017, 2017, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Figueras, J.; Ramos, E.; Lopez-Ben, S.; Torras, J.; Albiol, M.; Llado, L.; González, H.D.; Rafecas, A. Surgical treatment of liver metastases from colorectal carcinoma in elderly patients. When is it worthwhile? Clin. Transl. Oncol. 2007, 9, 392–400. [Google Scholar] [CrossRef]
- Adam, R.; Frilling, A.; Elias, D.; Laurent, C.; Ramos, E.; Capussotti, L.; Poston, G.J.; Wicherts, D.A.; de Haas, R.J. Liver Re-section of Colorectal Metastases in Elderly Patients. Br. J. Surg. 2010, 97, 366–376. [Google Scholar] [CrossRef] [PubMed]
- Zacharias, T.; Jaeck, D.; Oussoultzoglou, E.; Bachellier, P.; Weber, J.-C. First and Repeat Resection of Colorectal Liver Metastases in Elderly Patients. Ann. Surg. 2004, 240, 858–865. [Google Scholar] [CrossRef] [PubMed]
- Nachmany, I.; Pencovich, N.; Zohar, N.; Goykhman, Y.; Lubezky, N.; Nakache, R.; Klausner, J.M. Resection of colorectal liver metastases in the elderly-Is it justified? J. Surg. Oncol. 2016, 113, 485–488. [Google Scholar] [CrossRef] [PubMed]
- Van Tuil, T.; Dhaif, A.A.; Riele, W.W.T.; van Ramshorst, B.; van Santvoort, H.C. Systematic Review and Meta-Analysis of Liver Resection for Colorectal Metastases in Elderly Patients. Dig. Surg. 2019, 36, 111–123. [Google Scholar] [CrossRef] [Green Version]
- Kim, S.; Kim, D.H.; Park, S.-Y.; Park, C.H.; Kim, H.S.; Choi, S.K.; Rew, J.S. Association between Charlson comorbidity index and complications of endoscopic resection of gastric neoplasms in elderly patients. BMC Gastroenterol. 2020, 20, 213. [Google Scholar] [CrossRef]
- Tian, Y.; Jian, Z.; Xu, B.; Liu, H. Age-adjusted Charlson comorbidity index score as predictor of survival of patients with digestive system cancer who have undergone surgical resection. Oncotarget 2017, 8, 79453–79461. [Google Scholar] [CrossRef] [Green Version]
- Sourdet, S.; Brechemier, D.; Steinmeyer, Z.; Gerard, S.; Balardy, L. Impact of the Compre-hensive Geriatric Assessment on Treatment Decision in Geriatric Oncology. BMC Cancer 2020, 20, 384. [Google Scholar] [CrossRef] [PubMed]
- Torres, C.H.; Hsu, T. Comprehensive Geriatric Assessment in the Older Adult with Cancer: A Review. Eur. Urol. Focus 2017, 3, 330–339. [Google Scholar] [CrossRef]
- Feng, M.A.; McMillan, D.T.; Crowell, K.; Muss, H.; Nielsen, M.E.; Smith, A.B. Geriatric Assessment in Surgical Oncolo-gy: A Systematic Review. J. Surg. Res. 2015, 193, 265–272. [Google Scholar] [CrossRef] [Green Version]
- Yokom, D.W.; Alibhai, S.M.; Sattar, S.; Krzyzanowska, M.K.; Puts, M.T. Geriatric oncology screening tools for CGA-based interventions: Results from a phase II study of geriatric assessment and management for older adults with cancer. J. Geriatr. Oncol. 2018, 9, 683–686. [Google Scholar] [CrossRef]
- Mitry, E.; Fields, A.L.; Bleiberg, H.; Labianca, R.; Portier, G.; Tu, D.; Nitti, D.; Torri, V.; Elias, D.; O’Callaghan, C.; et al. Adjuvant Chemotherapy after Po-tentially Curative Resection of Metastases from Colorectal Cancer: A Pooled Analysis of Two Randomized Trials. J. Clin. Oncol. 2008, 26, 4906–4911. [Google Scholar] [CrossRef] [PubMed]
- Benedix, F.; Kube, R.; Meyer, F.; Schmidt, U.; Gastinger, I.; Lippert, H. Comparison of 17,641 Patients With Right- and Left-Sided Colon Cancer: Differences in Epidemiology, Perioperative Course, Histology, and Survival. Dis. Colon Rectum 2010, 53, 57–64. [Google Scholar] [CrossRef] [PubMed]
- Suttie, S.A.; Shaikh, I.; Mullen, R.; Amin, A.I.; Daniel, T.; Yalamarthi, S. Outcome of right- and left-sided colonic and rectal cancer following surgical resection. Color. Dis. 2010, 13, 884–889. [Google Scholar] [CrossRef] [PubMed]
- Heinemann, V.; von Weikersthal, L.F.; Decker, T.; Kiani, A.; Vehling-Kaiser, U.; Al-Batran, S.; Heintges, T.; Lerchenmüller, C.; Kahl, C.; Seipelt, G.; et al. Folfiri Plus Cetuximab Versus Folfiri Plus Bevacizumab as First-Line Treatment for Patients with Metastatic Colorectal Cancer (Fire-3): A Randomised, Open-Label, Phase 3 Trial. Lancet Oncol. 2014, 15, 1065–1075. [Google Scholar] [CrossRef]
- Boeckx, N.; Koukakis, R.; de Beeck, K.O.; Rolfo, C.; van Camp, G.; Siena, S.; Tabernero, J.; Douillard, J.Y.; André, T.; Peeters, M. Primary Tumor Sidedness Has an Impact on Prognosis and Treatment Outcome in Metastatic Colorectal Cancer: Results from Two Randomized First-Line Panitumumab Studies. Ann. Oncol. 2017, 28, 1862–1868. [Google Scholar] [CrossRef] [PubMed]
- Weiss, J.M.; Pfau, P.R.; O’Connor, E.S.; King, J.; LoConte, N.; Kennedy, G.; Smith, M.A. Mortality by Stage for Right- Versus Left-Sided Colon Cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare Data. J. Clin. Oncol. 2011, 29, 4401–4409. [Google Scholar] [CrossRef] [Green Version]
- Engstrand, J.; Strömberg, C.; Nilsson, H.; Freedman, J.; Jonas, E. Synchronous and Metachronous Liver Metastases in Pa-tients with Colorectal Cancer-Towards a Clinically Relevant Definition. World J. Surg. Oncol. 2019, 17, 228. [Google Scholar] [CrossRef]
- Suthananthan, A.E.; Bhandari, M.; Platell, C. Influence of primary site on metastatic distribution and survival in stage IV colorectal cancer. ANZ J. Surg. 2017, 88, 445–449. [Google Scholar] [CrossRef]
- Zhao, Y.; Deng, Y.; Peng, J.; Sui, Q.; Lin, J.; Qiu, M.; Pan, Z. Does the Preoper-ative Prognostic Nutritional Index Predict Survival in Patients with Liver Metastases from Colorectal Cancer Who Under-went Curative Resection? J. Cancer 2018, 9, 2167–2174. [Google Scholar] [CrossRef] [PubMed]
- Mantovani, A.; Romero, P.; Palucka, A.K.; Marincola, F.M. Tumour immunity: Effector response to tumour and role of the microenvironment. Lancet 2008, 371, 771–783. [Google Scholar] [CrossRef]
- Mallappa, S.; Sinha, A.; Gupta, S.; Chadwick, S.J. Preoperative Neutrophil to Lymphocyte Ratio >5 Is a Prognostic Factor for Recurrent Colorectal Cancer. Colorectal. Dis. 2013, 15, 323–328. [Google Scholar] [CrossRef] [PubMed]
- Walsh, S.; Cook, E.; Goulder, F.; Justin, T.; Keeling, N. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J. Surg. Oncol. 2005, 91, 181–184. [Google Scholar] [CrossRef] [PubMed]
- Dimitriou, N.; Felekouras, E.; Karavokyros, I.; Alexandrou, A.; Pikoulis, E.; Griniatsos, J. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. BMC Cancer 2018, 18, 1202. [Google Scholar] [CrossRef] [PubMed]
Characteristics | Number of Patients (%) |
---|---|
Modified Charlson Comorbidity Index | |
4 | 25 (11.9%) |
5 | 76 (36.2%) |
6 | 66 (31.4%) |
7 | 35 (16.7%) |
8 | 8 (3.8%) |
Primary Tumor Site | |
Right Colon | 80 (38%) |
Left Colon | 89 (42.3%) |
Rectum | 40 (19%) |
Unknown | 1 (0.4%) |
Staging of primary tumor T stage | |
T1 | 5 (2.4%) |
T2 | 31 (14.8%) |
T3 | 129 (61.4%) |
T4 | 29 (13.8%) |
Unknown | 16 (7.6%) |
Liver metastases only | 175 (83.3%) |
Liver and Lung metastases | 19 (9%) |
Localization of Liver Metastases | |
Right Lobe | 115 (54.7%) |
Left Lobe | 89 (42.3%) |
Both | 4 (2%) |
Central | 2 (1%) |
Number of Liver Metastases | |
1 | 116 (55.2%) |
2 | 39 (18.6%) |
3 | 29 (13.8%) |
4 | 14 (6.7%) |
5 | 6 (2.8%) |
6 | 6 (2.8%) |
Timing of liver Metastases | |
Synchronous | 118 (56.2%) |
Metachronous | 92 (43.8%) |
Type of Hepatic Surgery | |
Central Hepatectomy | 12 (5.7%) |
Right Hepatectomy | 69 (32.9%) |
Left Hepatectomy | 41 (19.5%) |
Segmentectomy not defined | 79 (37.6%) |
Right segmentectomy | 6 (2.9%) |
Left Segmentectomy | 3 (1.4%) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nassabein, R.; Mansour, L.; Richard, C.; Vandenbroucke-Menu, F.; Aubin, F.; Ayoub, J.-P.; Dagenais, M.; Lapointe, R.; Letourneau, R.; Plasse, M.; et al. Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience. Curr. Oncol. 2021, 28, 1899-1908. https://doi.org/10.3390/curroncol28030176
Nassabein R, Mansour L, Richard C, Vandenbroucke-Menu F, Aubin F, Ayoub J-P, Dagenais M, Lapointe R, Letourneau R, Plasse M, et al. Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience. Current Oncology. 2021; 28(3):1899-1908. https://doi.org/10.3390/curroncol28030176
Chicago/Turabian StyleNassabein, Rami, Laura Mansour, Corentin Richard, Franck Vandenbroucke-Menu, Francine Aubin, Jean-Pierre Ayoub, Michel Dagenais, Real Lapointe, Richard Letourneau, Marylène Plasse, and et al. 2021. "Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience" Current Oncology 28, no. 3: 1899-1908. https://doi.org/10.3390/curroncol28030176
APA StyleNassabein, R., Mansour, L., Richard, C., Vandenbroucke-Menu, F., Aubin, F., Ayoub, J. -P., Dagenais, M., Lapointe, R., Letourneau, R., Plasse, M., Roy, A., Turcotte, S., & Tehfe, M. (2021). Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience. Current Oncology, 28(3), 1899-1908. https://doi.org/10.3390/curroncol28030176